CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

Hyerim Ha, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo

Cancer Research and Treatment. 2016;48(1):304-311. Published online 2015 April 9 DOI: https://doi.org/10.4143/crt.2014.339

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

Hyerim Ha, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo

Cancer Research and Treatment. 2016;48(1):304-311

Link1

Link2 Link3

Rituximab added to CHOP worth it among elderly patients with DLBCL

PharmacoEconomics & Outcomes News. 2005;480(1):6-6

Link1

Link2 Link3

High-dose chemotherapy and autologous stem-cell transplantation for DLBCL in the rituximab era

Michael Pfreundschuh

The Lancet Oncology. 2017;18(8):989-991

Link1 Link2

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients

Pier Luigi Zinzani, Cinzia Pellegrini, Enrico Derenzini, Lisa Argnani, Stefano Pileri

Hematological Oncology. 2013;31(4):223-224

Link1 Link2

Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma

Kensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, Akira Yokota

Hematology. 2018;24(1):52-59

Link1 Link2

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma

Robert I. Griffiths, Michelle L. Gleeson, Joseph Mikhael, Martin H. Dreyling, Mark D. Danese

Cancer. 2012;118(24):6079-6088

Link1 Link2

Effectiveness of dose reduced THP-COP like therapy with the addition of etoposide for elderly DLBCL patients

Yuko Tanaka, Seiichiro Yoshizawa, Yu Saito, Seiichiro Katagiri, Daigo Akahane, Hiroaki Fujimoto, Tetsuzo Tauchi, Yoshikazu Ito, Kazuma Ohyashiki

Annals of Oncology. 2017;28:ix111

Link1 Link2 Link3

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Antonino Musolino, Daniela Boggiani, Michele Panebianco

Cancer. 2011;117(15):3531-3531

Link1 Link2

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Alberto Febbri, Alessandro Gozzetti, Luigi Rigacci

Cancer. 2011;117(15):3530-3530

Link1 Link2

Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer. 2011;118(13):3446-3446

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.